title: Parenteral and oral antibiotic duration for treatment of pediatric osteomyelitis: a systematic review protocol.
abstract: BACKGROUND
  Pediatric osteomyelitis is a bacterial infection of bones requiring prolonged antibiotic treatment using parenteral followed by enteral agents. Major complications of pediatric osteomyelitis include transition to chronic osteomyelitis, formation of subperiosteal abscesses, extension of infection into the joint, and permanent bony deformity or limb shortening. Historically, osteomyelitis has been treated with long durations of antibiotics to avoid these complications. However, with improvements in management and antibiotic treatment, standard of care is moving towards short durations of intravenous antibiotics prior to enteral antibiotics.
  
  
  METHODS
  The authors will perform a systematic review based on PRISMA guidelines in order to evaluate the literature, looking for evidence to support the optimal duration of parenteral and enteral therapy. The main goals are to see if literature supports shorter durations of either parenteral antibiotics and/or enteral antibiotics.Multiple databases will be investigated using a thorough search strategy. Databases include Medline, Cochrane, EMBASE, SCOPUS, Dissertation Abstracts, CINAHL, Web of Science, African Index Medicus and LILACS. Search stream will include medical subject heading for pediatric patients with osteomyelitis and antibiotic therapy. We will search for published or unpublished randomized and quasi-randomized controlled trials.Two authors will independently select articles, extract data and assess risk of bias by standard Cochrane methodologies. We will analyze comparisons between dichotomous outcomes using risk ratios and continuous outcomes using mean differences. 95% confidence intervals will be computed.
  
  
  CONCLUSIONS
  One of the major dilemmas of management of this disease is the duration of parenteral therapy. Long parenteral therapy has increased risk of serious complications and the necessity for long therapy has been called into question. Our study aims to review the currently available evidence from randomized trials regarding duration of both parenteral and oral therapy for pediatric acute osteomyelitis.
  
  
  BACKGROUND
  CRD42013002320.
authors.affiliation: Department of Pediatrics, University of Alberta, Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, AB T6T 1C9, Canada. cgrimbly@ualberta.ca.
authors.forename: Chelsey
authors.initials: C
authors.lastname: Grimbly
authors.forename: Jeff
authors.initials: J
authors.lastname: Odenbach
authors.forename: Ben
authors.initials: B
authors.lastname: Vandermeer
authors.forename: Sarah
authors.initials: S
authors.lastname: Forgie
authors.forename: Sarah
authors.initials: S
authors.lastname: Curtis
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D016206:Databases, Bibliographic; D019317:Evidence-Based Medicine; D006801:Humans; D007223:Infant; D010019:Osteomyelitis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D000078202:Systematic Reviews as Topic
chemical_list: D000900:Anti-Bacterial Agents